DOJ Ends J&J Blood Reagent Price-Fixing Probe

Law360, New York (January 24, 2011, 1:45 PM EST) -- The U.S. Department of Justice has closed a criminal antitrust investigation into a Johnson & Johnson subsidiary over an alleged conspiracy to fix the prices of blood reagents, although a multidistrict litigation against the company continues.

Ortho-Clinical Diagnostics Inc. said the DOJ had informally notified the company that the investigation was closed in a Jan. 14 filing in a related multidistrict litigation in the U.S. District Court for the Eastern District of Pennsylvania.

The Rochester, N.Y.-based health care company first disclosed the DOJ investigation in a...
To view the full article, register now.